Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/12/2014 | CA2538349C Polypeptides having alpha-amylase activity and polynucleotides encoding same |
08/12/2014 | CA2528053C Phl p 5a derivatives having reduced allergenicity and retained t-cell reactivity |
08/12/2014 | CA2520392C Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
08/12/2014 | CA2490572C Pig binding protein from adipocytes |
08/12/2014 | CA2482893C Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
08/12/2014 | CA2367989C Diagnosis of whipple disease |
08/07/2014 | WO2014121303A1 Mechanochemical collagen assembly |
08/07/2014 | WO2014121210A1 Methods for producing diketopiperazines and compositions containing diketopiperazines |
08/07/2014 | WO2014121067A1 Collagen scaffolds |
08/07/2014 | WO2014120959A1 Monomeric and bright infrared fluorescent proteins |
08/07/2014 | WO2014120714A1 Compositions and methods for the expansion of stem cells |
08/07/2014 | WO2014120619A2 Compositions and methods of use in treating metabolic disorders |
08/07/2014 | WO2014120026A1 Treatment and prevention of acne |
08/07/2014 | WO2014118552A1 Inhibition of the complement system |
08/07/2014 | WO2014118346A1 Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure |
08/07/2014 | WO2014118297A1 Novel chimeric polypeptides for screening and drug discovery purposes |
08/07/2014 | WO2014118296A1 Methods for treating mitochondrial disorders and neurodegenerative disorders |
08/07/2014 | WO2014118236A2 High avidity antigen recognizing constructs |
08/07/2014 | WO2014118018A1 Fungal resistant plants expressing ein2 |
08/07/2014 | WO2014117990A1 Fungal resistant plants expressing hcp6 |
08/07/2014 | WO2014117988A1 Fungal resistant plants expressing hcp7 |
08/07/2014 | WO2014089169A3 Immunotherapy with binding agents |
08/07/2014 | WO2014044626A3 Process for producing gelatin employing aspergillopepsin ii |
08/07/2014 | WO2014020129A3 Allatostatin-b peptides for inducing the settlement of lophotrochozoan marine larvae |
08/07/2014 | US20140223601 Genes that increase plant oil and method for using the same |
08/07/2014 | US20140223599 Axmi279 pesticidal gene and methods for its use |
08/07/2014 | US20140223596 Use of jaz5a for improving drought-resistance in a plant |
08/07/2014 | US20140223588 A2m fragments and applications thereof |
08/07/2014 | US20140222569 Communicating a targeted message to a wireless device based on location and two user profiles |
08/07/2014 | US20140221944 Wound spray |
08/07/2014 | US20140221636 Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof |
08/07/2014 | US20140221628 Influenza virus-like particles comprising adjuvant-fused m2 protein to enhance the immunogenicity of vaccine |
08/07/2014 | US20140221618 Targeted coagulation factors and method of using the same |
08/07/2014 | US20140221617 Canola protein product with low phytic acid content ("c702") |
08/07/2014 | US20140221614 Collagen matrix with locally controlled intrafibrillar and extrafibrillar mineral content and methods of producing |
08/07/2014 | US20140221613 Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g |
08/07/2014 | US20140221611 Binding molecules for human factor viii and factor viii-like proteins |
08/07/2014 | US20140221608 Acid-cleavable linkers exhibiting altered rates of acid hydrolysis |
08/07/2014 | US20140221606 Aspart Proinsulin Compositions and Methods of Producing Aspart Insulin Analogs |
08/07/2014 | US20140221296 Methods of phosvitin extraction and phosphopeptide preparation from egg yolk |
08/07/2014 | US20140221293 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
08/07/2014 | US20140221291 Compositions and Methods for Modulating Thrombin Generation |
08/07/2014 | US20140221287 Amylin Peptides and Derivatives and Uses Thereof |
08/07/2014 | US20140221283 Glucagon/glp-1 receptor co-agonists |
08/07/2014 | US20140221281 Dual glp1/gip or trigonal glp1/gip/glucagon agonists |
08/07/2014 | US20140221280 Novel compounds and their effects on feeding behaviour |
08/07/2014 | US20140221273 Anti-Microbial Peptides and Methods of Use Thereof |
08/07/2014 | US20140221270 Methoxypolyethyleneglycol succinimidyl propionate modified recombinant ganoderma immunoregulatory protein, preparing method and application thereof |
08/07/2014 | US20140220679 Methods and compositions for categorizing patients |
08/07/2014 | US20140220678 Methods and compositions relating to improved lentiviral vectors and their applications |
08/07/2014 | US20140220674 System for expression of genes in plants |
08/07/2014 | US20140220636 PHAGE &phgr;MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF |
08/07/2014 | US20140220632 Engineered Sequences to Facilitate Expression of Antigens in Neisseria and Methods of Use |
08/07/2014 | US20140220631 Rapid Screening Method of Translational Fusion Partners for Producing Recombinant Proteins and Translational Fusion Partners Screened Therefrom |
08/07/2014 | US20140220629 Novel branchiostoma derived fluorescent proteins |
08/07/2014 | US20140220627 Degradable Clostridial Toxins |
08/07/2014 | US20140220605 Vmp-like sequences of pathogenic borrelia species and strains |
08/07/2014 | US20140220600 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
08/07/2014 | US20140220577 Methods of Using Improved Polymerases |
08/07/2014 | US20140220117 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of Cancer |
08/07/2014 | US20140220107 Truncated hiv envelope proteins (env), methods and compositions related thereto |
08/07/2014 | US20140220075 Multi plasmid system for the production of influenza virus |
08/07/2014 | US20140220072 Shigella-derived vector and methods of using the same |
08/07/2014 | US20140220066 Group a streptococcus multivalent vaccine |
08/07/2014 | US20140220060 Hiv-1 south african subtype c env proteins |
08/07/2014 | US20140220038 Lrp1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (vldl) to ischaemic cardiac muscle |
08/07/2014 | US20140220025 Novel stip1 polypeptides and uses thereof |
08/07/2014 | US20140220016 Antibody- endostatin fusion protein and its variants |
08/07/2014 | US20140220014 Levels of bcma protein expression on b cells and use in diagnostic methods |
08/07/2014 | US20140220013 Method for the diagnosis and prognosis of malignant diseases |
08/07/2014 | US20140220012 Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders |
08/07/2014 | US20140220011 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
08/07/2014 | US20140220004 Compositions and methods for treating pain |
08/07/2014 | US20140219988 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof |
08/07/2014 | US20140219983 Suppression of cancers |
08/07/2014 | US20140219978 Gp100-specific t cell receptors and related materials and methods of use |
08/07/2014 | US20140219975 Switch costimulatory receptors |
08/07/2014 | US20140219974 Targeted delivery of proteins across the blood-brain barrier |
08/07/2014 | US20140219971 Algal produced malarial transmission blocking vaccines |
08/07/2014 | US20140219959 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins |
08/07/2014 | US20140219955 Fusion molecules and il-15 variants |
08/07/2014 | DE102010039019B4 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use |
08/07/2014 | DE102005051789B4 Der Botulinus Neurotoxin A Proteinrezeptor und seine Anwendungen The botulinum neurotoxin A receptor protein and its applications |
08/06/2014 | EP2762498A1 Modified plant defensin |
08/06/2014 | EP2762489A1 Glycosylated polypeptide and pharmaceutical composition containing same |
08/06/2014 | EP2762488A2 Peptide for synthesizing silica, and use thereof |
08/06/2014 | EP2762166A1 Antigen-binding molecule for promoting loss of antigens |
08/06/2014 | EP2762164A1 Influenza antigen delivery vectors and constructs |
08/06/2014 | EP2762149A2 Erythropoietin-derived peptide and use therefor |
08/06/2014 | EP2761298A1 Bin1 expression as a marker of cancer |
08/06/2014 | EP2761015A1 Identification of antigen-specific adaptive immune responses using arm-pcr and high-throughput sequencing |
08/06/2014 | EP2761011A2 Use of non-subtype b gag proteins for lentiviral packaging |
08/06/2014 | EP2761010A1 LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS |
08/06/2014 | EP2761007A1 Growth enhancement of plants |
08/06/2014 | EP2761006A1 Split inteins and uses thereof |
08/06/2014 | EP2760892A1 Multi-specific binding molecules targeting aberrant cells |
08/06/2014 | EP2760887A1 Compositions and methods for modulating hemostasis |
08/06/2014 | EP2760886A1 Immunocytokine combination therapy |
08/06/2014 | EP2760885A2 Chimeric polypeptides having beta-glucosidase activity and polynucleotides encoding same |
08/06/2014 | EP2760884A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |